(Q45738783)

English

The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study

scientific article published on 14 March 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

The adolescent outcome of children with attention deficit hyperactivity disorder treated with methylphenidate or methylphenidate combined with multimodal behaviour therapy: results of a naturalistic follow-up study (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

attention deficit hyperactivity disorder

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

author name string

S van der Oord

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

P J M Prins

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

J Oosterlaan

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

14 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Clinical Psychology & Psychotherapy

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

270-278

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type.

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

Lessons from large trials: the MTA study as a model for evaluating the treatment of childhood psychiatric disorder

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

Effectiveness of behavioral parent training for children with ADHD in routine clinical practice: a randomized controlled study.

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

3-Year Follow-up of the NIMH MTA Study

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

Families of children with attention-deficit/hyperactivity disorder: review and recommendations for future research

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

Design and rationale of controlled study of long-term methylphenidate and multimodal psychosocial treatment in children with ADHD.

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

The MTA at 8 Years: Prospective Follow-up of Children Treated for Combined-Type ADHD in a Multisite Study

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD.

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

Does brief, clinically based, intensive multimodal behavior therapy enhance the effects of methylphenidate in children with ADHD?

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

Efficacy of methylphenidate, psychosocial treatments and their combination in school-aged children with ADHD: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

The NIMH multimodal treatment study for attention-deficit hyperactivity disorder: just say yes to drugs alone?

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

Delinquent Behavior and Emerging Substance Use in the MTA at 36 Months: Prevalence, Course, and Treatment Effects

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

Effects of Stimulant Medication on Growth Rates Across 3 Years in the MTA Follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

21 January 2018

Young adult follow-up of hyperactive children: antisocial activities and drug use

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

7 January 2021

based on heuristic

inferred from DOI database lookup

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

7 January 2021

based on heuristic

inferred from DOI database lookup

Teacher ratings of DSM-III-R symptoms for the disruptive behavior disorders

1 reference

https://api.crossref.org/works/10.1002%2FCPP.750

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CPP.750

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45738783&oldid=2079863278"